NODE NEGATIVE BREAST CANCER
Clinical trials for NODE NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new NODE NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for NODE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shot aims to stop early breast cancer from returning
Disease control OngoingThis Phase 2 trial is testing whether a combination of two targeted drugs (trastuzumab and pertuzumab) given as a single shot under the skin, along with standard hormone therapy, can prevent cancer from returning after surgery in people with early-stage, hormone receptor-positive…
Matched conditions: NODE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Hormone pills before surgery may improve breast cancer outcomes
Disease control OngoingThis study tests whether giving 6 months of hormone therapy before surgery helps remove all cancer cells in women with early-stage, estrogen-positive breast cancer. It involves 8 postmenopausal women with low-risk, node-negative tumors. The goal is to see if this approach leads t…
Matched conditions: NODE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Irada Ibrahim-zada • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC